Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 20 mg - ruxolitinib - ruxolitinib - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi israel ltd - immunoglobulin rabbit anti-human thymocyte - אבקה להכנת תמיסה מרוכזת לעירוי - immunoglobulin rabbit anti-human thymocyte 25 mg/vial - antithymocyte immunoglobulin (rabbit) - antithymocyte immunoglobulin (rabbit) - immunosuppression in transplantation: prevention and treatment of graft rejection. treatment of acute graft versus host disease (gvhd). hematology treatment of aplastic anemia.

Ισραήλ - Εβραϊκά - Ministry of Health

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.03 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Ισραήλ - Εβραϊκά - Ministry of Health

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.1 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Ισραήλ - Εβραϊκά - Ministry of Health

tzamal bio-pharma ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 300 mcg / 0.5 ml - filgrastim

Ισραήλ - Εβραϊκά - Ministry of Health

tzamal bio-pharma ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 480 mcg / 0.5 ml - filgrastim

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 10 mg - ruxolitinib

Ισραήλ - Εβραϊκά - Ministry of Health

tzamal bio-pharma ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 300 mcg / 0.5 ml - filgrastim

Ισραήλ - Εβραϊκά - Ministry of Health

tzamal bio-pharma ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 480 mcg / 0.5 ml - filgrastim

Ισραήλ - Εβραϊκά - Ministry of Health

דר מ.בורשטיין בעמ - עיצוב השיער